Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Edwards Lifesciences Reaffirms 2026 Guidance Following Medicare TAVR Decision

Edwards Lifesciences Reaffirms 2026 Guidance Following Medicare TAVR Decision

MT newswireMT newswire2026/09/11 08:25
04:25 AM EDT, 09/11/2026 (MT Newswires) -- Edwards Lifesciences (EW) said Thursday it has maintained its 2026 financial outlook after US health regulators released an updated national coverage decision for transcatheter aortic valve replacement. The adoption of the revised coverage policy is expected to require time to take effect, the company said. The company plans to share its 2027 and long-term financial projections at an investor conference in December, it said.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. consumer confidence drops to a four-month low in September, short-term inflation expectations rise to 4.6%

As rising energy prices further exacerbate concerns about the cost of living for American households, U.S. consumer confidence continued to deteriorate in September, falling to its lowest level in four months.

智通财经•2026/09/25 14:36
U.S. consumer confidence drops to a four-month low in September, short-term inflation expectations rise to 4.6%